Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Green Energie
In Vino Veritas
The Vegan Market
French state ownership
Education
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Green Energie
In Vino Veritas
The Vegan Market
French state ownership
Education
Water
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Other OTC
>
CytoDyn Inc.
CYDY
CYTODYN INC.
(CYDY)
Add to my list
Report
Delayed Other OTC -
03/05 03:59:53 pm
4.05
USD
-0.25%
03/05
CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil
GL
03/05
CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
GL
03/03
CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about CYTODYN INC.
03/05
CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and..
GL
03/05
CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and..
GL
03/03
CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
02/22
CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding..
GL
02/05
INSIDER TRENDS
: Insider at CytoDyn Converts Options in Mist of 90-Day Buying Tr..
MT
02/01
CYTODYN
: Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compass..
AQ
01/29
Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate S..
GL
01/05
CYTODYN
: to Hold Webcast on January 6 to Provide Timelines for Clinical and Re..
AQ
01/04
REMINDER
: CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinica..
GL
2020
CytoDyn Announces Research on Critically Ill COVID-19 Patients Published in J..
GL
2020
FDA Accepts Protocol for Adding an Open-Label Extension to CytoDyn's Phase 3 ..
GL
2020
CYTODYN
: to Hold Webcast on January 6 to Provide Timelines for Clinical and Re..
AQ
2020
CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Re..
GL
2020
FDA Provides Guidance for Adding an Open-Label Extension to CytoDyn's Phase 3..
GL
2020
FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyr..
GL
More most relevant news
All news about CYTODYN INC.
03/05
CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and..
GL
03/05
CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and..
GL
03/03
CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
03/02
CYTODYN INC.
: Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/22
CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding..
GL
02/05
INSIDER TRENDS
: Insider at CytoDyn Converts Options in Mist of 90-Day Buying Tr..
MT
02/01
CYTODYN
: Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compass..
AQ
01/29
Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate S..
GL
01/29
CYTODYN INC.
: Entry into a Material Definitive Agreement, Unregistered Sale of..
AQ
01/08
CYTODYN
: Management's Discussion and Analysis of Financial Condition and Resul..
AQ
More news
News in other languages on CYTODYN INC.
2020
CYTODYN INC.
: protocole d'accord pour mener un essai clinique COVID-19
More news
Press releases
03/05
CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and..
GL
03/05
CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and..
GL
03/03
CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
03/02
CYTODYN INC.
: Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/22
CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding..
GL
More press releases
Powered by Scoopnest.com
Analysis
Coronavirus crushes Australia's dividends with banks leading the decline
More Must read
Upcoming sector events
03/16/21
DENALI THERAPEUTICS INC.
:
03/25/21
EVOTEC SE
:
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs
Master